Table III.
KEGG pathway analysis of DEGs.
| A, Upregulated | ||
|---|---|---|
| Pathway description | Observed gene count | FDR |
| Metabolic pathways | 197 | 1.71×10−38 |
| Huntington's disease | 47 | 1.58×10−15 |
| Ribosome | 37 | 7.29×10−14 |
| Oxidative phosphorylation | 36 | 5.91×10−13 |
| Parkinson's disease | 37 | 7.94×10−13 |
| B, Downregulated | ||
| Pathway description | Observed gene count | FDR |
| Osteoclast differentiation | 46 | 1.66×10−21 |
| Tuberculosis | 53 | 6.51×10−21 |
| Chemokine signaling pathway | 53 | 4.78×10−20 |
| Natural killer cell-mediated cytotoxicity | 43 | 2.71×10−19 |
| Influenza A | 47 | 6.17×10−17 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; FDR, false discovery rate.